Article Versions Notes

Urwanisch L, Unger MS, Sieberer H, Dang H-H, Neuper T, Regl C, Vetter J, Schaller S, Winkler SM, Kerschbamer E, et al. The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells. Cancers. 2023; 15(4):1039. https://doi.org/10.3390/cancers15041039

Urwanisch, Laura, Michael Stefan Unger, Helene Sieberer, Hieu-Hoa Dang, Theresa Neuper, Christof Regl, Julia Vetter, Susanne Schaller, Stephan M. Winkler, Emanuela Kerschbamer, and et al. 2023. "The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells" Cancers 15, no. 4: 1039. https://doi.org/10.3390/cancers15041039

Urwanisch, L., Unger, M. S., Sieberer, H., Dang, H. -H., Neuper, T., Regl, C., Vetter, J., Schaller, S., Winkler, S. M., Kerschbamer, E., Weichenberger, C. X., Krenn, P. W., Luciano, M., Pleyer, L., Greil, R., Huber, C. G., Aberger, F., & Horejs-Hoeck, J. (2023). The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells. Cancers, 15(4), 1039. https://doi.org/10.3390/cancers15041039